Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus + Irinotecan + Cetuximab in mCRC
NCT00522665Phase 2Completed
- Sponsor
- Hoosier Cancer Research Network
- Start
- Aug 2007
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in colorectal cancer (CRC), sponsored by Hoosier Cancer Research Network. Started Aug 2007; status: completed.
02
Drugs
everolimus
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00522665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00522665.